# Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment

- Source: PR Newswire M&A
- Published: 2026-11-03T23:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/samsung-biologics-achieves-negligible-risk-rating-in-sustainalytics-esg-assessment-302927620.html
- Canonical: https://groundlevelnews.com/story/samsung-biologics-achieves-negligible-risk-rating-in-sustainalytics-es-1a8468/

Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry Advances from 'Low Risk' to 'Negligible Risk,' the lowest ESG risk category Recognition reflects continued improvements in ESG risk management across operations INCHEON, South Korea, Nov. 3,...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._